Predictive blood group genetics in hemolytic disease of the fetus and newborn: A 10-year review of a laboratory evaluation of amniotic fluid-derived DNA

Prenatal Diagnosis

Volumn 27, Issue 11, 2007, Pages 1017-1023

  Seto, Eva ^a,b   Fernandes, Bernard J ^a,b   Wang, Chen ^a,b   Denomme, Gregory A ^a,b,c,d  

^a Pediatric Oral and Maxillofacial Surgery   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

^c CANADIAN BLOOD SERVICES   (Canada)

^d MOUNT SINAI HOSPITAL   (Canada)

Author keywords

Fetal blood group genotyping; Hemolytic disease of the fetus and newborn; Predictive genetics

Indexed keywords

ANTIGEN; DNA;

AMNION FLUID ANALYSIS; ARTICLE; BLOOD GROUP; CANADA; CELL CULTURE; CONTROLLED STUDY; FATHER; FETUS; FETUS BLOOD; GENE AMPLIFICATION; GENETICS; GENOTYPE; HEMOLYTIC ANEMIA; HETEROZYGOTE; HUMAN; HUMAN TISSUE; LABORATORY TEST; NEWBORN; POLYMERASE CHAIN REACTION; PREDICTION; PREGNANT WOMAN; PRIORITY JOURNAL; RETROSPECTIVE STUDY;

ALGORITHMS; AMNIOTIC FLUID; BLOOD GROUPING AND CROSSMATCHING; DNA; ERYTHROBLASTOSIS, FETAL; FEMALE; GENETIC SCREENING; HUMANS; INFANT, NEWBORN; MALE; PREGNANCY; PRENATAL DIAGNOSIS; REPRODUCIBILITY OF RESULTS; RETROSPECTIVE STUDIES; SPECIMEN HANDLING;

EID: 36148970417     PISSN: 01973851     EISSN: 10970223     Source Type: Journal    
DOI: 10.1002/pd.1824     Document Type: Article

References (31)

1. Avent ND, Martin PG. 1996. Kell typing by allele-specific PCR (ASP). Br J Haematol 93: 728-730.
2. Bennett PR, Le Van Kim C, Colin Y, et al. 1993. Prenatal determination of fetal RhD type by DNA amplification. N Engl J Med 329: 607-610.
3. Bowman JM, Pollock JM, Manning FA, Harman CR, Menticoglou S. 1992. Maternal Kell blood group alloimmunization. Obstet Gynecol 79: 239-244.
4. Chang HC, Jones OW. 1991. Enhancement of amniocyte growth on a precoated surface. Prenat Diagn 11: 357-370.
5. Daniels G, Finning K, Martin P, Summers J. 2006. Fetal blood group genotyping: present and future. Ann N Y Acad Sci 1075: 88-95.
6. Denomme G, Rios M, Reid M. 2000. Molecular Protocols in Transfusion Medicine. Academic Press: San Diego, CA.
7. Denomme GA, Akoury H, Sermer M, Kelton JG. 1999. RhD status of a fetus at risk for haemolytic disease with a discrepant maternal DNA-based RhD genotype. Prenat Diagn 19: 424-427.
8. Ellis WD, Mulvaney BD, Saathoff DJ. 1975. Leukocyte isolation by sedimentation: the effect of rouleau-promoting agents on leukocyte differential count. Prep Biochem 5: 179-187.
9. Geifman-Holtzman O, Bernstein IM, Berry SM, Bianchi DW, Holtzman EJ. 1996. Rapid molecular determination of fetal rhesus E type. Prenat Diagn 16: 489-493.
10. Hecht F, Peakman DC, Kaiser-McCaw B, Robinson A. 1981. Amniocyte clones for prenatal cytogenetics. Am J Med Genet 10: 51-54.
11. Heckerling PS, Verp MS. 1991. Amniocentesis or chorionic villus sampling for prenatal genetic testing: a decision analysis. J Clin Epidemiol 44: 657-670.
12. Hoehn H, Bryant EM, Karp LE, Martin GM. 1974. Cultivated cells from diagnostic amniocentesis in second trimester pregnancies. I. Clonal morphology and growth potential. Pediatr Res 8: 746-754.
13. Hoehn H, Bryant EM, Karp LE, Martin GM. 1975. Cultivated cells from diagnostic amniocentesis in second trimester pregnancies. II. Cytogenetic parameters as functions of clonal type and preparative technique. Clin Genet 7: 29-36.
14. Huang CH, Guizzo ML, McCreary J, Leigh EM, Blumenfeld OO. 1991. Typing of MNSs blood group specific sequences in the human genome and characterization of a restriction fragment tightly linked to S-s-alleles. Blood 77: 381-386.
15. Le Van Kim C, Mouro I, Brossard Y, Chavinie J, Cartron JP, Colin Y. 1994. PCR-based determination of Rhc and RhE status of fetuses at risk of Rhc and RhE haemolytic disease. Br J Haematol 88: 193-195.
16. Lee S, Wu X, Reid M, Zelinski T, Redman C. 1995. Molecular basis of the Kell (K1) phenotype. Blood 85: 912-916.
17. Lo YM, Hjelm NM, Fidler C, et al. 1998. Prenatal diagnosis of fetal RhD status by molecular analysis of maternal plasma. N Engl J Med 339: 1734-1738.
18. Maaskant-Van Wijk PA, Faas BH, De Ruijter JA, et al. 1998. Genotyping of RHD by multiplex polymerase chain reaction analysis of six RHD-specific exons. Transfusion 38: 1015-1021.
19. Mari G, Deter RL, Carpenter RL, et al. 2000. Noninvasive diagnosis by Doppler ultrasonography of fetal anemia due to maternal red-cell alloimmunization. Collaborative Group for Doppler Assessment of the Blood Velocity in Anemic Fetuses. N Engl J Med 342: 9-14.
20. Martin JA, Hamilton BE, Sutton PD, Ventura SJ, Menacker F, Munson ML. 2002. Births: final data for 2002. Natl Vital Stat Rep 52: 1-116.
21. Matheson KA, Denomme GA. 2002. Novel 3′Rhesus box sequences confound RHD zygosity assignment. Transfusion 42: 645-650.
22. Mourant A. 1976. The Distribution of Human Blood Groups and other Polymorphisms. Oxford University Press: London.
23. Nagy B, Ban Z, Papp Z. 2005. Effect of the DNA isolation method on the results of multiple fluorescent PCR and DNA fragment analysis. Orv Hetil 146: 1539-1541.
24. Oepkes D, Seaward PG, Vandenbussche FP, et al. 2006. Doppler ultrasonography versus amniocentesis to predict fetal anemia. N Engl J Med 355: 156-164.
25. Simsek S, Bleeker PM, Von Dem Borne AE. 1994. Prenatal determination of fetal RhD type. N Engl J Med 330: 795-796.
26. Simsek S, Faas BH, Bleeker PM, et al. 1995. Rapid Rh D genotyping by polymerase chain reaction-based amplification of DNA. Blood 85: 2975-2980.
27. Singleton BK, Green CA, Avent ND, et al. 2000. The presence of an RHD pseudogene containing a 37 base pair duplication and a nonsense mutation in africans with the Rh D-negative blood group phenotype. Blood 95: 12-18.
28. Tellez A, Rubinstein P. 1970. Rapid method for separation of blood cells. Transfusion 10: 223-225.
29. Tournamille C, Le Van Kim C, Gane P, Cartron JP, Colin Y. 1995. Molecular basis and PCR-DNA typing of the Fya/fyb blood group polymorphism. Hum Genet 95: 407-410.
30. Wagner FF, Flegel WA. 2000. RHD gene deletion occurred in the Rhesus box. Blood 95: 3662-3668.
31. Wahlstrom J, Brosset A, Bartsch F. 1970. Viability of amniotic cells at different stages of gestation. Lancet 2: 1037.